Bionano Genomics Inc. (BNGO)
NASDAQ: BNGO
· Real-Time Price · USD
3.70
0.03 (0.82%)
At close: Jun 12, 2025, 3:59 PM
3.72
0.52%
After-hours: Jun 12, 2025, 07:59 PM EDT
Bionano Genomics Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|
| Product and Service, Other Revenue | 3.77M | 9.39M | 700K | 600K | 3.14M | 2.71M | 537.56K |
| Product and Service, Other Revenue Growth | -59.87% | +1241.29% | +16.67% | -80.92% | +15.96% | +404.50% | n/a |
| Product Revenue | 27.01M | 26.73M | 20.43M | 11.7M | 3.08M | 6.76M | 11.46M |
| Product Revenue Growth | +1.05% | +30.85% | +74.65% | +279.11% | -54.38% | -41.01% | n/a |
| Consumable Revenue Revenue | 12.77M | 11.16M | 6.73M | 5.81M | 2.27M | 655.06K | n/a |
| Consumable Revenue Revenue Growth | +14.48% | +65.76% | +15.89% | +155.48% | +247.05% | n/a | n/a |
| Instrument Revenue Revenue | 8.04M | 10M | 8.57M | 5.89M | 6.23M | 9.47M | n/a |
| Instrument Revenue Revenue Growth | -19.56% | +16.72% | +45.52% | -5.50% | -34.25% | n/a | n/a |
| Software Revenue Revenue | 6.19M | 5.57M | 5.13M | n/a | n/a | n/a | n/a |
| Software Revenue Revenue Growth | +11.15% | +8.66% | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|
| Americas Revenue | 13.65M | 18.02M | 13.86M | 3.05M | 850.93K | 1.47M | 3.45M |
| Americas Revenue Growth | -24.26% | +30.00% | +354.79% | +258.20% | -42.18% | -57.36% | n/a |
| Asia Pacific Revenue | 2.89M | 5.13M | 4.98M | 5.6M | 3.16M | 3.63M | 3.95M |
| Asia Pacific Revenue Growth | -43.64% | +3.07% | -11.13% | +77.19% | -12.82% | -8.27% | n/a |
| Emea Revenue | 14.23M | 12.96M | 8.96M | n/a | n/a | n/a | n/a |
| Emea Revenue Growth | +9.80% | +44.68% | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 9.03M | 11.75M | 9.46M | 11.56M | 20.18M | 10.77M | 24.9M | 26.94M | 25.98M | 25.32M | 21.22M | 21.78M | 20.28M | 19.81M | 15.33M | 13.83M | 9.53M | 9.43M | 8.66M | 5.61M | 7.37M | 5.86M | 4.45M | 5.06M | 4.79M | 4.6M | 3.22M | 3.49M | 2.9M | 3.53M | 3.12M | 3.92M | 3.51M |
| Selling, General, and Administrative Revenue Growth | -23.10% | +24.11% | -18.11% | -42.72% | +87.32% | -56.74% | -7.57% | +3.70% | +2.59% | +19.35% | -2.60% | +7.43% | +2.37% | +29.23% | +10.83% | +45.14% | +1.05% | +8.89% | +54.27% | -23.82% | +25.74% | +31.71% | -12.00% | +5.54% | +4.09% | +42.75% | -7.62% | +20.53% | -17.89% | +13.13% | -20.55% | +11.68% | n/a |
| Research and Development Revenue | 2.37M | 3.47M | 4.72M | 6.83M | 9.78M | 11.7M | 13.79M | 14.61M | 13.94M | 14.01M | 12.74M | 11.77M | 10.53M | 9.21M | 6.5M | 4.09M | 2.68M | 2.88M | 2.3M | 2.4M | 2.67M | 2.4M | 2.17M | 2.41M | 2.1M | 2.52M | 2.51M | 2.1M | 2.37M | 2.46M | 2.97M | 3.39M | 3.19M |
| Research and Development Revenue Growth | -31.78% | -26.35% | -30.95% | -30.15% | -16.43% | -15.12% | -5.65% | +4.83% | -0.53% | +9.96% | +8.29% | +11.78% | +14.24% | +41.66% | +59.20% | +52.58% | -6.92% | +24.87% | -4.04% | -10.21% | +11.45% | +10.36% | -9.71% | +14.65% | -16.71% | +0.65% | +19.36% | -11.33% | -3.68% | -17.17% | -12.58% | +6.39% | n/a |